Molecular Weight Marker Market size was valued at US$ 598.08 Mn. in 2021 and the total revenue is expected to grow at 12.31 % through 2021 to 2029, reaching nearly US$ 1513.94 Mn.Molecular Weight Marker Market Overview:
Molecular weight markers are used to calculate the size of a molecule when it is passed through gel electrophoresis. It is associated to the protein pyramid, the DNA ladder, and the RNA ladder. The molecular weight markers are either run on agarose gel or polyacrylamide gel. Before the electrophoresis procedure begins, the molecular weight markers are put next to the sample lane. This procedure aids in the determination of the size and weight of an unfamiliar molecule. These indicators can also be applied to genome, gene, and disease studies.To know about the Research Methodology :- Request Free Sample Report
Molecular Weight Marker Market Dynamics:
The growth is coupled with the increased popularity of personalized medicines for the treatment of chronic diseases and genetic disorders. Personalized medicines involve the application of molecular weight markers for the study of individual’s genome, genes, and diseases. Thus, growing adoption of personalized medicines along with the escalating focus on molecular biology research is expected to boost the demand for molecular weight marker products. Technological advancement in molecular biology products, such as PCR and NGS along with high-quality molecular weight Global Molecular Weight Marker is another major factor contributing towards growth. The recent advancement in these products enables provision of a clearer background and sharp bands. Thus, the demand for molecular weight marker products is expected upsurge soon, which is expected to boost growth. Increasing R&D investments by the pharmaceutical and biopharmaceutical industries are likely to drive the global molecular weight marker market during the forecast period. Increased collaboration between pharmaceutical and biopharmaceutical producers, as well as university research organisations for molecular genetics, is also likely to drive the global molecular weight marker market during the forecast period. However, a crucial factor restraining the global molecular weight marker market's growth throughout the forecast period is a paucity of qualified professionals.
Molecular Weight Marker Market Segment Analysis:
The global Molecular Weight Marker Market is segmented by Products, Type, Applications and End-Use. Based on Type, the global Molecular Weight Marker market is segmented into Prestained markers, Unstained markers and Specialty markers. The Prestained markers segment held the largest market share of xx% in 2021. Due to the large application of this product for genomics and proteomics research. Other factors include an ability to provide more accurate molecular weight determinations of the sample over a wide molecular weight range. Thus, the popularity of this product is increasing, which is expected to propel the growth of the Global Molecular Weight Marker.Based on End-Use, the global Molecular Weight Marker market is segmented into Academic and research institutes, Pharmaceutical and biotechnology companies, CRO's and Others. The Academic and research institutes segment held the largest market share of xx% in 2021. Because large and small organizations have increased funding for biological research. Emphasis is placed on research-based genomics, such as genotyping, cell genomics, gene function, epigenetic analysis, and transcriptome analysis, which is increasing the use of molecular weight markers in academic and research centers.
Molecular Weight Marker Market Regional Insights:
North America held the largest market share of xx% with such a revenue of USD 142.6 million in 2021 owing to the presence of many large research laboratories and biotechnology firms such as CELGENE CORP. and Amgen Inc. In addition, the highly developed healthcare and research infrastructure in this region have fuelled the Global Molecular Weight Marker growth. Asia Pacific is expected to grow at a highest CAGR of 11.6% in the global Molecular Weight Marker market during the forecast period owing to rising focus of CROs and biotechnology companies in this region for drug discovery and development. The CROs are focusing on Asian countries such as China and India for clinical trials owing to less stringent government regulations and the availability of skilled professionals. These are some of the factors projected to boost the regional Global Molecular Weight Marker growth. The objective of the report is to present a comprehensive analysis of the global Molecular Weight Marker Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also helps in understanding the global Molecular Weight Marker Market dynamic, structure by analyzing the market segments and project the global Molecular Weight Marker Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Molecular Weight Marker Market make the report investor’s guide.Global Molecular Weight Marker Market Scope: Inquire before buying
Global Molecular Weight Marker Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 598.08 Mn. Forecast Period 2022 to 2029 CAGR: 12.31% Market Size in 2029: US $ 1513.4 Mn. Segments Covered: by Product • DNA markers o Below 50 bp o 50 bp to 100 bp o 100 bp to 1 kb o 1 kb to 5 kb o Above 5 kb • Protein markers o Below 10 kDa o 10 k Da to 100 kDa o 100 k Da to 200 kDa o Above 200 kDa • RNA markers by Type • Prestained markers • Unstained markers • Specialty markers by Application •Nucleic acid applications o PCR o Sequencing o Northern blotting o Southern blotting o Molecular cloning o Others • Proteomics applications o Western blotting o Gel extraction o Others by End-User • Academic and Research Institutes • Pharmaceutical and Biotechnology Companies • CROs • Others Molecular Weight Marker Market, by Region
• North America • Europe • Asia Pacific • South America • Middle East and AfricaMolecular Weight Marker Market Key Players are:
• Abcam Plc • Agilent Technologies Inc. • Bio-Rad Laboratories Inc. • F. Hoffmann-La Roche Ltd. • Merck KGaA • New England Biolabs Inc. • Promega Corp. • QIAGEN NV • Takara Bio Inc. • Thermo Fisher Scientific Inc. • Horiba • Avomeen • Biohelix Corp • Halo Medical • Abbott • The Crest Group • John Morris Group • GE Healthcare Life Sciences • Malvern Instruments • Brookhaven Instruments Corporation • Sigma-AldrichFrequently Asked Questions:
1] What segments are covered in Molecular Weight Marker Market report? Ans. The segments covered in Molecular Weight Marker Market report are based on Products, Type, Applications and End-Use. 2] Which region is expected to hold the highest share in the global Molecular Weight Marker Market? Ans. North America is expected to hold the highest share in the global Molecular Weight Marker Market. 3] What is the market size of global Molecular Weight Marker Market by 2029? Ans. The market size of global Molecular Weight Marker Market by 2029 is US $ 1513.94 Mn. 4] Who are the top key players in the global Molecular Weight Marker Market? Ans. Abcam Plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA and New England Biolabs Inc. are the top key players in the global Molecular Weight Marker Market. 5] What was the market size of global Molecular Weight Marker Market in 2021? Ans. The market size of global Molecular Weight Marker Market in 2021 was US $ 598.08 Mn. 6] By Type, What segments are covered in global Molecular Weight Marker Market report? Ans. The segments covered in global Molecular Weight Marker Market report by type are Prestained markers, Unstained markers and Specialty markers.
Global Molecular Weight Marker Market
Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Molecular Weight Marker Market overview 2.1.1. By Products 2.1.2. By Type 2.1.3. By Applications 2.1.4. By End-Use Chapter 3 Global Molecular Weight Marker Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Increased demand for personalized medicines for the treatment of chronic diseases 3.3. Market share analysis 3.3.1. By Products 3.3.2. By Type 3.3.3. By Applications 3.3.4. By End-Use 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Molecular Weight Marker Market, By Type 4.1. Key segment trends 4.2. Prestained markers 4.2.1. Market size, by region, 2013 - 2024 4.3. Unstained markers 4.3.1. Market size, by region, 2021-2029 4.4. Specialty markers 4.1. Market size, by region, 2021-2029 4.2. Key Trends in Global Molecular Weight Marker Market Chapter 5 Molecular Weight Marker Market, By Products 5.1. Key segment trends 5.2. DNA markers 5.2.1. Market size, by region, 2013 - 2024 5.3. Below 50 bp 5.3.1. Market size, by region, 2021-2029 5.4. 50 bp to 100 bp 5.4.1. Market size, by region, 2021-2029 5.5. 100 bp to 1 kb 5.5.1. Market size, by region, 2013 - 2024 5.6. 1 kb to 5 kb 5.6.1. Market size, by region, 2021-2029 5.7. Above 5 kb 5.7.1. Market size, by region, 2021-2029 5.8. Protein markers 5.8.1. Market size, by region, 2021-2029 5.9. Below 10 kDa 5.9.1. Market size, by region, 2021-2029 5.10. 10 k Da to 100 kDa 5.10.1. Market size, by region, 2021-2029 5.11. 100 k Da to 200 kDa 5.11.1. Market size, by region, 2021-2029 5.12. Above 200 kDa 5.12.1. Market size, by region, 2021-2029 5.13. RNA markers 5.13.1. Market size, by region, 2021-2029 Chapter 6 Molecular Weight Marker Market, By Applications 6.1. Key segment trends 6.2. Nucleic acid applications 6.2.1. Market size, by region, 2013 - 2024 6.3. PCR 6.3.1. Market size, by region, 2021-2029 6.4. Sequencing 6.4.1. Market size, by region, 2021-2029 6.5. Northern blotting 6.5.1. Market size, by region, 2021-2029 6.6. Southern blotting 6.6.1. Market size, by region, 2021-2029 6.7. Molecular cloning 6.7.1. Market size, by region, 2021-2029 6.8. Others 6.8.1. Market size, by region, 2021-2029 6.9. Proteomics applications 6.9.1. Market size, by region, 2021-2029 6.10. Western blotting 6.10.1. Market size, by region, 2021-2029 6.11. Gel extraction 6.11.1. Market size, by region, 2021-2029 6.12. Others 6.12.1. Market size, by region, 2021-2029 Chapter 7 Molecular Weight Marker Market, By Applications 7.1. Key segment trends 7.2. Academic and research institutes 7.2.1. Market size, by region, 2013 - 2024 7.3. Pharmaceutical and biotechnology companies 7.3.1. Market size, by region, 2021-2029 7.4. CRO's 7.4.1. Market size, by region, 2021-2029 7.5. Others 7.5.1. Market size, by region, 2021-2029 Chapter 8 Molecular Weight Marker Market, By Region 8.1. Key regional trends 8.2. North America 8.2.1. Market size, by country, 2021-2029 8.2.2. Market size, by products, 2021-2029 8.2.3. Market size, by type, 2021-2029 8.2.4. Market size, by applications, 2021-2029 8.2.5. Market size, by end-use, 2021-2029 8.2.6. U.S. 8.2.6.1. Market size, by products, 2021-2029 8.2.6.2. Market size, by type, 2021-2029 8.2.6.3. Market size, by applications, 2021-2029 8.2.6.4. Market size, by end-use, 2021-2029 8.2.7. Canada 8.2.7.1. Market size, by products, 2021-2029 8.2.7.2. Market size, by type, 2021-2029 8.2.7.3. Market size, by applications, 2021-2029 8.2.7.4. Market size, by end-use, 2021-2029 8.3. Europe 8.3.1. Market size, by country, 2021-2029 8.3.2. Market size, by products, 2021-2029 8.3.3. Market size, by type, 2021-2029 8.3.4. Market size, by applications, 2021-2029 8.3.5. Market size, by end-use, 2021-2029 8.3.6. Germany 8.3.6.1. Market size, by products, 2021-2029 8.3.6.2. Market size, by type, 2021-2029 8.3.6.3. Market size, by applications, 2021-2029 8.3.6.4. Market size, by end-use, 2021-2029 8.3.7. UK 8.3.7.1. Market size, by products, 2021-2029 8.3.7.2. Market size, by type, 2021-2029 8.3.7.3. Market size, by applications, 2021-2029 8.3.7.4. Market size, by end-use, 2021-2029 8.3.8. France 8.3.8.1. Market size, by products, 2021-2029 8.3.8.2. Market size, by type, 2021-2029 8.3.8.3. Market size, by applications, 2021-2029 8.3.8.4. Market size, by end-use, 2021-2029 8.3.9. Spain 8.3.9.1. Market size, by products, 2021-2029 8.3.9.2. Market size, by type, 2021-2029 8.3.9.3. Market size, by applications, 2021-2029 8.3.9.4. Market size, by end-use, 2021-2029 8.3.10. Italy 8.3.10.1. Market size, by products, 2021-2029 8.3.10.2. Market size, by type, 2021-2029 8.3.10.3. Market size, by applications, 2021-2029 8.3.10.4. Market size, by end-use, 2021-2029 8.4. Asia Pacific 8.4.1. Market size, by country, 2021-2029 8.4.2. Market size, by products, 2021-2029 8.4.3. Market size, by type, 2021-2029 8.4.4. Market size, by applications, 2021-2029 8.4.5. Market size, by end-use, 2021-2029 8.4.6. India 8.4.6.1. Market size, by products, 2021-2029 8.4.6.2. Market size, by type, 2021-2029 8.4.6.3. Market size, by applications, 2021-2029 8.4.6.4. Market size, by end-use, 2021-2029 8.4.7. China 8.4.7.1. Market size, by products, 2021-2029 8.4.7.2. Market size, by type, 2021-2029 8.4.7.3. Market size, by applications, 2021-2029 8.4.7.4. Market size, by end-use, 2021-2029 8.4.8. Japan 8.4.8.1. Market size, by products, 2021-2029 8.4.8.2. Market size, by type, 2021-2029 8.4.8.3. Market size, by applications, 2021-2029 8.4.8.4. Market size, by end-use, 2021-2029 8.4.9. Australia 8.4.9.1. Market size, by products, 2021-2029 8.4.9.2. Market size, by type, 2021-2029 8.4.9.3. Market size, by applications, 2021-2029 8.4.9.4. Market size, by end-use, 2021-2029 8.5. Latin America 8.5.1. Market size, by country, 2021-2029 8.5.2. Market size, by products, 2021-2029 8.5.3. Market size, by type, 2021-2029 8.5.4. Market size, by applications, 2021-2029 8.5.5. Market size, by end-use, 2021-2029 8.5.6. Argentina 8.5.6.1. Market size, by products, 2021-2029 8.5.6.2. Market size, by type, 2021-2029 8.5.6.3. Market size, by applications, 2021-2029 8.5.6.4. Market size, by end-use, 2021-2029 8.5.7. Brazil 8.5.7.1. Market size, by products, 2021-2029 8.5.7.2. Market size, by type, 2021-2029 8.5.7.3. Market size, by applications, 2021-2029 8.5.7.4. Market size, by end-use, 2021-2029 8.5.8. Mexico 8.5.8.1. Market size, by products, 2021-2029 8.5.8.2. Market size, by type, 2021-2029 8.5.8.3. Market size, by applications, 2021-2029 8.5.8.4. Market size, by end-use, 2021-2029 8.6. Middle East and Africa 8.6.1. Market size, by country, 2021-2029 8.6.2. Market size, by products, 2021-2029 8.6.3. Market size, by type, 2021-2029 8.6.4. Market size, by applications, 2021-2029 8.6.5. Market size, by end-use, 2021-2029 8.6.6. South Africa 8.6.6.1. Market size, by products, 2021-2029 8.6.6.2. Market size, by type, 2021-2029 8.6.6.3. Market size, by applications, 2021-2029 8.6.6.4. Market size, by end-use, 2021-2029 8.6.7. Saudi Arabia 8.6.7.1. Market size, by products, 2021-2029 8.6.7.2. Market size, by type, 2021-2029 8.6.7.3. Market size, by applications, 2021-2029 8.6.7.4. Market size, by end-use, 2021-2029 Chapter 9 Consolidations 9.1. Mergers and Acquisitions 9.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 9.3. Patent Analysis 9.4. Key players 9.4.1. F Hoffmann-La Roche AG 9.4.1.1. Company overview 9.4.1.2. Key financials 9.4.1.3. Product landscape 9.4.1.4. Strategic initiatives 9.4.1.5. SWOT analysis 9.4.2. Thermo Fisher Scientific Inc. 9.4.2.1. Company overview 9.4.2.2. Key financials 9.4.2.3. Product landscape 9.4.2.4. Strategic initiatives 9.4.2.5. SWOT analysis 9.4.3. Agilent Technologies 9.4.3.1. Company overview 9.4.3.2. Key financials 9.4.3.3. Product landscape 9.4.3.4. Strategic initiatives 9.4.3.5. SWOT analysis 9.4.4. Sigma-Aldrich 9.4.4.1. Company overview 9.4.4.2. Key financials 9.4.4.3. Product landscape 9.4.4.4. Strategic initiatives 9.4.4.5. SWOT analysis 9.4.5. Affymetrix, Inc. 9.4.5.1. Company overview 9.4.5.2. Key financials 9.4.5.3. Product landscape 9.4.5.4. Strategic initiatives 9.4.5.5. SWOT analysis 9.4.6. QIAGEN 9.4.6.1. Company overview 9.4.6.2. Key financials 9.4.6.3. Product landscape 9.4.6.4. Strategic initiatives 9.4.6.5. SWOT analysis 9.4.7. Takara Bio Inc. 9.4.7.1. Company overview 9.4.7.2. Key financials 9.4.7.3. Product landscape 9.4.7.4. Strategic initiatives 9.4.7.5. SWOT analysis 9.4.8. Bio-Rad Laboratories 9.4.8.1. Company overview 9.4.8.2. Key financials 9.4.8.3. Product landscape 9.4.8.4. Strategic initiatives 9.4.8.5. SWOT analysis 9.4.9. Promega Corporation 9.4.9.1. Company overview 9.4.9.2. Key financials 9.4.9.3. Product landscape 9.4.9.4. Strategic initiatives 9.4.9.5. SWOT analysis 9.4.10. New England Biolabs 9.4.10.1. Company overview 9.4.10.2. Key financials 9.4.10.3. Product landscape 9.4.10.4. Strategic initiatives 9.4.10.5. SWOT analysis 9.4.11. VWR International 9.4.11.1. Company overview 9.4.11.2. Key financials 9.4.11.3. Product landscape 9.4.11.4. Strategic initiatives 9.4.11.5. SWOT analysis 9.4.12. Affymetrix, Inc. 9.4.12.1. Company overview 9.4.12.2. Key financials 9.4.12.3. Product landscape 9.4.12.4. Strategic initiatives 9.4.12.5. SWOT analysis 9.4.13. Sequenom Inc. 9.4.13.1. Company overview 9.4.13.2. Key financials 9.4.13.3. Product landscape 9.4.13.4. Strategic initiatives 9.4.13.5. SWOT analysis 9.4.14. 23andMe 9.4.14.1. Company overview 9.4.14.2. Key financials 9.4.14.3. Product landscape 9.4.14.4. Strategic initiatives 9.4.14.5. SWOT analysis 9.4.15. Bayer Diagnostics 9.4.15.1. Company overview 9.4.15.2. Key financials 9.4.15.3. Product landscape 9.4.15.4. Strategic initiatives 9.4.15.5. SWOT analysis 9.4.16. Biocartis 9.4.16.1. Company overview 9.4.16.2. Key financials 9.4.16.3. Product landscape 9.4.16.4. Strategic initiatives 9.4.16.5. SWOT analysis 9.4.17. BioHelix 9.4.17.1. Company overview 9.4.17.2. Key financials 9.4.17.3. Product landscape 9.4.17.4. Strategic initiatives 9.4.17.5. SWOT analysis 9.4.18. BioMerieux 9.4.18.1. Company overview 9.4.18.2. Key financials 9.4.18.3. Product landscape 9.4.18.4. Strategic initiatives 9.4.18.5. SWOT analysis 9.4.19. BGI 9.4.19.1. Company overview 9.4.19.2. Key financials 9.4.19.3. Product landscape 9.4.19.4. Strategic initiatives 9.4.19.5. SWOT analysis 9.4.20. Counsyl 9.4.20.1. Company overview 9.4.20.2. Key financials 9.4.20.3. Product landscape 9.4.20.4. Strategic initiatives 9.4.20.5. SWOT analysis 9.4.21. deCODEme 9.4.21.1. Company overview 9.4.21.2. Key financials 9.4.21.3. Product landscape 9.4.21.4. Strategic initiatives 9.4.21.5. SWOT analysis 9.4.22. Genentech 9.4.22.1. Company overview 9.4.22.2. Key financials 9.4.22.3. Product landscape 9.4.22.4. Strategic initiatives 9.4.22.5. SWOT analysis 9.4.23. Genomictree 9.4.23.1. Company overview 9.4.23.2. Key financials 9.4.23.3. Product landscape 9.4.23.4. Strategic initiatives 9.4.23.5. SWOT analysis 9.4.24. IntegraGen 9.4.24.1. Company overview 9.4.24.2. Key financials 9.4.24.3. Product landscape 9.4.24.4. Strategic initiatives 9.4.24.5. SWOT analysis 9.4.25. LabCorp Diagnostic 9.4.25.1. Company overview 9.4.25.2. Key financials 9.4.25.3. Product landscape 9.4.25.4. Strategic initiatives 9.4.25.5. SWOT analysis